News

News2025-11-05T11:31:26+11:00

For all media enquiries please contact Jennifer Durante, Director of Community & Engagement.
Email media@melanoma.org.au Phone 0412 798 990.

A second penicillin moment for cancer treatment

December 14th, 2022|Categories: Research News|Tags: , , |

In a world-first, an early phase trial of an mRNA personalised cancer vaccine has shown promising results for preventing melanoma recurrence in patients with resected high-risk melanoma (stage III and IV).

Comments Off on A second penicillin moment for cancer treatment
Go to Top